Tech led gains in US stock futures on Monday, after the Senate took a big step toward ending the record-breaking government shutdown that has clouded the picture of the economy.
S&P 500 futures (ES=F) rose 0.9%, while those on the tech-heavy Nasdaq 100 (NQ=F) climbed 1.4%. Contracts on the Dow Jones Industrial Average (YM=F), which includes fewer tech names, added 0.4%.
Markets have turned upbeat amid optimism that the 39-day US shutdown could soon come to an end, after a weekend of deal-making in Washington. A new bill was released late Sunday and quickly advanced in a key Senate procedural vote, after enough Democrats joined with Republicans to avoid a filibuster.
The prolonged shutdown has taken a toll on consumer confidence and the overall economy, with consumer sentiment dropping to just above record lows. Meanwhile, it has disrupted federal services and delayed key economic data releases, such as the Consumer Price Index (CPI) and Producer Price Index (PPI) inflation readings and the monthly jobs report.
Next up for the bill is a vote for final passage in the chamber, though its fate in the House remains uncertain. While it would reopen the government through Jan. 30, among other funding provisions, the deal lacks any immediate vote on the extension of healthcare subsidies earlier demanded by Democrats.
The moves higher come after a bumpy week on Wall Street, which saw the worst tech sell-off since April with the likes of Nvidia (NVDA) struggled to make headway amid persistent worries about an AI bubble and overbaked valuations.
This week, investors will turn their attention to corporate earnings, with tech releases from CoreWeave (CRWV), Oklo (OKLO), and Rocket Lab (RKLB). The entertainment sector will get a health check with results from The Walt Disney Company (DIS) and Paramount Skydance (PSKY).
LIVE 4 updates
-
Metsera slides after Novo pulls out of bidding war with Pfizer
Metsera (MTSR) shares sank 15% in premarket after Novo Nordisk (NVO, NOVO-B.CO) said it wouldn’t bump up its offer to buy the US developer of an experimental weight-loss drug.
By bowing out, the Danish pharma has called an end to a surprise bidding war with rival Pfizer (PFE) to buy the startup. Metsera stock on Friday closed at over four times its IPO value in January as the takeover bids came in.
Shares of Novo ticked 1.4% higher before the bell, while Pfizer shares were little changed.
Blooomberg reports:
Read more here.
-
Elon Musk’s pay package is a clear signal that Tesla is done being just a car company
Yahoo Finance’s Hamza Shaban lays out the takeaway from the Tesla (TSLA) shareholder vote:
Read more here.
-
TSMC stock rises as Wall Street eyes Nvidia supplier’s sales update
Shares of TSMC (TSM, 2330.TW) rose in premarket as investors digested monthly sales figures from the world’s biggest contract chipmaker.
The supplier to Nvidia (NVDA) — formally named Taiwanese Semiconductor Manufacturing Co. — posted a 16.9% year-on-year rise in revenue for October amid resilient AI demand. Sales for this year to the end of October rose 33.8%, compared with the same period in 2024.
But October’s monthly growth was the slowest pace since February 2024, per Bloomberg. That could underscore recent worries about the staying power of the AI boom.
Bloomberg reports:
Read more here.
-
Gold gains for second consecutive day following strong pullback from record high
Bloomberg reports:
Read more here.
